BioNexus Gene Lab (BGLC) Income from Continuing Operations (2018 - 2026)
BioNexus Gene Lab recorded quarterly Income from Continuing Operations of 543575.0 in Q1 2026, up 47.54% quarter-over-quarter from 1036117.0 in Q4 2025, and up 12.79% year-over-year from 481915.94 in Q1 2025.
BioNexus Gene Lab's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 543575.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 12.79% year-over-year to 543575.0; the TTM figure through Mar 2026 stood at 2904855.0 (down 38.42% YoY), while the FY2025 annual figure was 2984607.0, down 89.01% from the prior year.
- Income from Continuing Operations came in at 543575.0 for Q1 2026 at BioNexus Gene Lab, up from 1036117.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 351515.0 in Q4 2023 to a low of 2609189.0 in Q3 2023.
- A 5-year average of 464966.59 and a median of 291231.0 in 2023 frame the typical range for Income from Continuing Operations.
- On a YoY basis, Income from Continuing Operations climbed as much as 771.48% in 2023 and fell as far as 3271.0% in 2023.
- BioNexus Gene Lab's Income from Continuing Operations stood at 52349.0 in 2022, then soared by 771.48% to 351515.0 in 2023, then plunged by 193.6% to 329026.0 in 2024, then sank by 214.9% to 1036117.0 in 2025, then soared by 47.54% to 543575.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 543575.0, 1036117.0, and 708991.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 1.86 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | 402.90 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 534.70 Mn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 568.60 Mn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 724.80 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 385.00 Mn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 139.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 406.66 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 150.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -543,575.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -543,575.00 |
| Dec 31, 2025 | -1.04 Mn |
| Sep 30, 2025 | -708,991.00 |
| Jun 30, 2025 | -616,172.00 |
| Mar 31, 2025 | -623,327.00 |
| Dec 31, 2024 | -341,331.00 |
| Sep 30, 2024 | -1.35 Mn |
| Jun 30, 2024 | 199,104.00 |
| Mar 31, 2024 | -63,621.00 |
| Dec 31, 2023 | 351,515.00 |
| Sep 30, 2023 | -2.61 Mn |
| Jun 30, 2023 | -291,231.00 |
| Mar 31, 2023 | -37,086.00 |
| Dec 31, 2022 | -153,071.00 |
| Sep 30, 2022 | -77,401.00 |
| Jun 30, 2022 | -138,662.00 |
| Mar 31, 2022 | 17,066.00 |
| Dec 31, 2021 | 115,979.00 |
| Sep 30, 2021 | 295,322.00 |
| Jun 30, 2021 | 28,262.00 |
| Mar 31, 2021 | 338,744.00 |
| Dec 31, 2020 | -179,079.00 |
| Sep 30, 2020 | 235,442.00 |
| Jun 30, 2020 | -35,841.00 |
| Mar 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | -95,236.00 |
| Sep 30, 2019 | -78,248.00 |
| Jun 30, 2019 | -70,398.00 |
| Mar 31, 2019 | -58,939.00 |
| Dec 31, 2018 | -63,719.00 |
| Sep 30, 2018 | -55,142.00 |
| Mar 31, 2018 | 24,058.00 |